PL4522144T3 - Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniu - Google Patents
Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniuInfo
- Publication number
- PL4522144T3 PL4522144T3 PL23726112.8T PL23726112T PL4522144T3 PL 4522144 T3 PL4522144 T3 PL 4522144T3 PL 23726112 T PL23726112 T PL 23726112T PL 4522144 T3 PL4522144 T3 PL 4522144T3
- Authority
- PL
- Poland
- Prior art keywords
- creatine
- treatment
- composition
- breathing difficulties
- breathing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22172901.5A EP4275680A1 (en) | 2022-05-12 | 2022-05-12 | Composition comprising creatine for use in the treatment of breathing difficulties |
| EP22187487.8A EP4311549A1 (en) | 2022-07-28 | 2022-07-28 | Composition comprising creatine for use in the treatment of post viral fatigue syndrome |
| EP23154842 | 2023-02-03 | ||
| EP23154844 | 2023-02-03 | ||
| PCT/EP2023/062670 WO2023217993A1 (en) | 2022-05-12 | 2023-05-11 | Composition comprising creatine for use in the treatment of breathing difficulties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4522144T3 true PL4522144T3 (pl) | 2026-05-11 |
Family
ID=86558783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23726112.8T PL4522144T3 (pl) | 2022-05-12 | 2023-05-11 | Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniu |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20250325505A1 (pl) |
| EP (2) | EP4522144B1 (pl) |
| JP (2) | JP7781310B2 (pl) |
| CN (2) | CN119173259A (pl) |
| ES (1) | ES3064989T3 (pl) |
| PL (1) | PL4522144T3 (pl) |
| WO (2) | WO2023217994A1 (pl) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160137528A (ko) * | 2014-02-07 | 2016-11-30 | 유니버시티 오브 유타 리서치 파운데이션 | 크레아틴, 오메가-3 지방산 및 시티콜린의 조합 |
| GB2596849A (en) * | 2020-07-10 | 2022-01-12 | Jardine Romy | Nutritional supplement composition for treating coronavirus infections, cancer, ME, post viral & Chronic fatigue syndrome & neurodegeneration in an individual |
-
2023
- 2023-05-11 EP EP23726112.8A patent/EP4522144B1/en active Active
- 2023-05-11 CN CN202380039880.0A patent/CN119173259A/zh active Pending
- 2023-05-11 ES ES23726112T patent/ES3064989T3/es active Active
- 2023-05-11 EP EP23726362.9A patent/EP4522145A1/en active Pending
- 2023-05-11 JP JP2024562107A patent/JP7781310B2/ja active Active
- 2023-05-11 US US18/864,416 patent/US20250325505A1/en active Pending
- 2023-05-11 CN CN202380039990.7A patent/CN119255795A/zh active Pending
- 2023-05-11 US US18/864,432 patent/US20250302788A1/en active Pending
- 2023-05-11 PL PL23726112.8T patent/PL4522144T3/pl unknown
- 2023-05-11 WO PCT/EP2023/062671 patent/WO2023217994A1/en not_active Ceased
- 2023-05-11 JP JP2024562030A patent/JP7781309B2/ja active Active
- 2023-05-11 WO PCT/EP2023/062670 patent/WO2023217993A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023217994A1 (en) | 2023-11-16 |
| ES3064989T3 (en) | 2026-04-30 |
| EP4522144A1 (en) | 2025-03-19 |
| WO2023217993A1 (en) | 2023-11-16 |
| EP4522144B1 (en) | 2026-03-11 |
| JP7781310B2 (ja) | 2025-12-05 |
| JP7781309B2 (ja) | 2025-12-05 |
| EP4522145A1 (en) | 2025-03-19 |
| EP4522144C0 (en) | 2026-03-11 |
| CN119173259A (zh) | 2024-12-20 |
| CN119255795A (zh) | 2025-01-03 |
| JP2025515582A (ja) | 2025-05-20 |
| US20250302788A1 (en) | 2025-10-02 |
| JP2025515584A (ja) | 2025-05-20 |
| US20250325505A1 (en) | 2025-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL297849B1 (en) | Composition for use in the treatment of APOL1-related disease | |
| IL315901A (en) | 5-MEO-DMT for use in the treatment of sleep disorders | |
| IL315897A (en) | 5-MEO-DMT for use in the treatment of sleep disorders | |
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| PL4340842T3 (pl) | Sotorasib do zastosowania w leczeniu nowotworów | |
| CA3264923A1 (en) | COMPOSITION INTENDED FOR USE IN THE TREATMENT OF FABRY'S DISEASE | |
| EP4445914A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMORS AND USE | |
| EP3960167A4 (en) | Use of pantothenic acid in preparation composition for treating and/or preventing tumors | |
| PL3773615T3 (pl) | Płynna kompozycja do stosowania w leczeniu błony śluzowej przewodu ustno-gardłowo-krtaniowo-przełykowego | |
| LT4048229T (lt) | Farmacinė kompozicija, skirta panaudoti įvairių etiologijų cistito gydymui | |
| IL282718A (en) | Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases | |
| IL284980B1 (en) | Heteroaryl-azacyclic-oxo-amide compound, pharmaceutical preparation and pharmaceutical preparation for use in the treatment | |
| PL3937949T3 (pl) | Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu upośledzenia funkcji oddechowych | |
| IL314205A (en) | Ramibrutinib for use in the treatment of hidradenitis suppurativa | |
| IL288307A (en) | Preparations for use in the treatment of insulin deficiency conditions | |
| IL297398B2 (en) | Pharmaceutical preparation containing L-triiodothyronine (T3) for use in the treatment of tissue hypoxia and sepsis | |
| IL315893A (en) | 5-MEO-DMT for use in the treatment of postpartum depression | |
| IL327100A (en) | Alsonarsen/PRAX-22 for use in the treatment of SCN2A-related disorders | |
| GB2610895B (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| GB202202541D0 (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| HK40088920A (en) | Methylthioninium compounds for use in the treatment of covid-19 | |
| HK40087864A (en) | Methylthioninium compounds for use in the treatment of covid-19 | |
| CA3302321A1 (en) | Compounds for use in the treatment of phenylketonuria | |
| GB202213305D0 (en) | Compositions for use in the treatment of diabetes or obesity | |
| PL3738596T3 (pl) | Związek i kompozycja do stosowania w leczeniu zespołu napięcia przedmiesiączkowego i/lub przedmiesiączkowego zaburzenia dysforycznego |